Influence of psychological and symptom burden on disease activity scores in patients with rheumatoid arthritis

Mohammad Imtiaz Sultan; Aparna Deb; Mohammed Taherul Islam; M. Saiful Arif; Protyay Dey; Ananya Bhattacharjee; Mohammad Kafil Uddin Chowdher; M. Salman Ibna Zaman; M. Jaber Abedin; Mrinal Saha; Toufiqul Islam

doi:10.18203/2320-6012.ijrms20260948

Authors

Mohammad Imtiaz Sultan Department of Rheumatology, Kurmitola General Hospital, Dhaka, Bangladesh
Aparna Deb Department of Medicine, Upazila Health Complex, Fatikchari, Chittagong, Bangladesh
Mohammed Taherul Islam Department of Medicine, Chittagong Medical College Hospital, Chittagong, Bangladesh
M. Saiful Arif Department of Rheumatology, Chittagong Medical College, Chittagong, Bangladesh
Protyay Dey Department of Nephrology, Chittagong Medical College, Chittagong, Bangladesh
Ananya Bhattacharjee Department of Medicine, BIRDEM General Hospital, Shahbagh, Dhaka, Bangladesh
Mohammad Kafil Uddin Chowdher Department of Rheumatology, Kurmitola General Hospital, Dhaka, Bangladesh
M. Salman Ibna Zaman Department of Medicine, Kurmitola General Hospital, Dhaka, Bangladesh
M. Jaber Abedin Department of Internal Medicine, Feni 250 bed General hospital, Feni, Bangladesh
Mrinal Saha Department of Medicine, Upazila Health Complex, Companigonj, Noakhali, Bangladesh
Toufiqul Islam Department of Biochemistry, Chittagong Medical College Hospital, Chittagong, Bangladesh

DOI:

https://doi.org/10.18203/2320-6012.ijrms20260948

Keywords:

Rheumatoid arthritis, DAS28, Depression, Fatigue, Disease activity, Patient-reported outcomes

Abstract

Background: Joint disease activity indices such as DAS28, CDAI, and SDAI are important for the treatment of rheumatoid arthritis (RA). Yet, indices are influenced by subjective components, which are likely to be reflective of impaired psychological and symptom burden with the former possibly confounding true calculation of inflammatory activity. Objective was to assess the impact of psychological factors and symptom burden on composite disease activity scores in patients with RA.

Methods: This cross-sectional analytical study selected 150 patients who fulfilled the criteria for diagnosis of RA by the ACR/EULAR in 2010. Clinical assessment comprised tender joint count and swollen joint count, patient global assessment, physician global assessment, ESR, and CRP. Depression and fatigue were measured by clinical examination and patient self–report. Disease activity was assessed based on DAS28, CDAI, and SDAI.

Results: The mean age was 52.02±12.13 years, and 81.3% were women. In the 36.0% and 48.0% of patients, depression and fatigue were detected, respectively. The average value of DAS28 was 4.28±1.25 (mean±SD)." Depressed patients also had a higher DAS28 (4.82±1.19 versus 3.97±1.18, p<0.001), CDAI and SDAI scores. Similar results were observed for individuals reporting fatigue (p<0.001). VAS-patient correlated most closely with DAS28 (r=0.49, p<0.001), and ESR and CRP demonstrated weak but not significant degree of correlation.

Conclusions: Psychosocial and symptom burden strongly contribute to the composite disease activity measures in RA. Disease activity scores must be interpreted in the context of psychosocial factors to prevent misclassification and unnecessary treatment step-up.

Metrics

Metrics Loading ...

References

Radner H, Smolen JS, Aletaha D. Impact of comorbidity on physical function in patients with rheumatoid arthritis. Ann Rheum Dis. 2010;69(3):536-41. DOI: https://doi.org/10.1136/ard.2009.118430

Dougados M, Aletaha D, van Riel P. Disease activity measures in rheumatoid arthritis: the choice of composite indices. Clin Exp Rheumatol. 2007;25(5):S22-9.

Ferreira RJ, Dougados M, Kirwan JR, Duarte C, de Wit M, Soubrier M, et al. Drivers of patient global assessment in rheumatoid arthritis. Arthritis Care Res (Hoboken). 2017;69(12):190-8.

Studenic P, Radner H, Smolen JS, Aletaha D. Discrepancies between patients and physicians in global assessment of disease activity in rheumatoid arthritis. Arthritis Rheum. 2012;64(9):2814-23. DOI: https://doi.org/10.1002/art.34543

Taylor PC, Moore A, Vasilescu R, Alvir J, Tarallo M. A structured literature review of patient-reported outcomes in rheumatoid arthritis. Clin Exp Rheumatol. 2016;34(3):456-63.

Katz PP, Morris A, Gregorich S, Yazdany J, Eisner MD, Yelin EH. Valued life activity disability in rheumatoid arthritis. Arthritis Rheum. 2004;51(5):711-20.

Wolfe F, Michaud K. Severe rheumatoid arthritis (RA), worse outcomes, and comorbid illness. J Rheumatol. 2004;31(4):695-700.

Treharne GJ, Lyons AC, Hale ED, Douglas KM, Kitas GD. Sleep disruption frequency in rheumatoid arthritis. J Rheumatol. 2007;34(12):2384-91.

Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388(10055):2023-38. DOI: https://doi.org/10.1016/S0140-6736(16)30173-8

Smolen JS, Breedveld FC, Burmester GR, Bykerk V, Dougados M, Emery P, et al. Treating rheumatoid arthritis to target: 2014 update of the recommendations. Ann Rheum Dis. 2016;75(1):3-15. DOI: https://doi.org/10.1136/annrheumdis-2015-207524

Prevoo ML, van’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight–joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38(1):44-8. DOI: https://doi.org/10.1002/art.1780380107

Aletaha D, Smolen JS. The Simplified Disease Activity Index (SDAI) and Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol. 2005;23(5):S100-8.

Aletaha D, Ward MM, Machold KP, Nell VP, Stamm T, Smolen JS. Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states. Arthritis Rheum. 2005;52(9):2625-36. DOI: https://doi.org/10.1002/art.21235

Pollard LC, Kingsley GH, Choy EH, Scott DL. Fibromyalgic rheumatoid arthritis and disease assessment. Rheumatology (Oxford). 2010;49(5):924-8. DOI: https://doi.org/10.1093/rheumatology/kep458

Matcham F, Rayner L, Steer S, Hotopf M. The prevalence of depression in rheumatoid arthritis: a meta-analysis. Rheumatology (Oxford). 2013;52(12):2136-48. DOI: https://doi.org/10.1093/rheumatology/ket169

Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 2010;62(5):600-10. DOI: https://doi.org/10.1002/acr.20140

Coury F, Rossat A, Tebib J, Letroublon MC, Maheu E, Gaudin P, et al. Rheumatoid arthritis and fibromyalgia: a frequent unrelated association complicating disease management. Arthritis Rheum. 2009;61(7):962-7. DOI: https://doi.org/10.3899/jrheum.080366

Ranzolin A, Brenol JC, Bredemeier M, Guarienti J, Rizzatti M, Feldman D, et al. Association of concomitant fibromyalgia with worse disease activity score in patients with rheumatoid arthritis. Rheumatol Int. 2009;29(6):645-50.